NCT06305767 2026-01-13INTerpath-005Merck Sharp & Dohme LLCPhase 1/2 Active not recruiting230 enrolled
NCT03544736 2023-03-22Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)Oslo University HospitalPhase 1/2 Active not recruiting30 enrolled